nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—SLC22A2—nephron—nephrolithiasis	0.176	0.462	CbGeAlD
Oxprenolol—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0739	0.149	CbGpPWpGaD
Oxprenolol—ADRB1—Endothelin Pathways—ADCY10—nephrolithiasis	0.0532	0.107	CbGpPWpGaD
Oxprenolol—Feeling cold—Hydrochlorothiazide—nephrolithiasis	0.0447	0.361	CcSEcCtD
Oxprenolol—CYP2D6—urine—nephrolithiasis	0.0446	0.117	CbGeAlD
Oxprenolol—SLC22A2—nephron tubule—nephrolithiasis	0.0379	0.0998	CbGeAlD
Oxprenolol—SLC22A2—renal system—nephrolithiasis	0.0345	0.0907	CbGeAlD
Oxprenolol—SLC22A2—kidney—nephrolithiasis	0.0333	0.0877	CbGeAlD
Oxprenolol—SLC22A2—cortex of kidney—nephrolithiasis	0.0325	0.0854	CbGeAlD
Oxprenolol—ADRB1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0221	0.0445	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0216	0.0435	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0186	0.0374	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0182	0.0366	CbGpPWpGaD
Oxprenolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0148	0.0298	CbGpPWpGaD
Oxprenolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0138	0.0277	CbGpPWpGaD
Oxprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0135	0.0273	CbGpPWpGaD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0132	0.0267	CbGpPWpGaD
Oxprenolol—CYP2D6—renal system—nephrolithiasis	0.0109	0.0287	CbGeAlD
Oxprenolol—CYP2D6—kidney—nephrolithiasis	0.0106	0.0278	CbGeAlD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0097	0.0196	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Other—CHRM3—nephrolithiasis	0.00959	0.0193	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00887	0.0179	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00887	0.0179	CbGpPWpGaD
Oxprenolol—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00848	0.0684	CcSEcCtD
Oxprenolol—ADRB1—G alpha (s) signalling events—PTH—nephrolithiasis	0.007	0.0141	CbGpPWpGaD
Oxprenolol—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.00685	0.0138	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00673	0.0136	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00673	0.0136	CbGpPWpGaD
Oxprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00661	0.0133	CbGpPWpGaD
Oxprenolol—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00654	0.0527	CcSEcCtD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00647	0.013	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00625	0.0126	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00625	0.0126	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00557	0.0112	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00553	0.0112	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00553	0.0112	CbGpPWpGaD
Oxprenolol—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00494	0.0398	CcSEcCtD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00493	0.00994	CbGpPWpGaD
Oxprenolol—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00476	0.0384	CcSEcCtD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00451	0.00909	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00451	0.00909	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00448	0.00903	CbGpPWpGaD
Oxprenolol—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00447	0.036	CcSEcCtD
Oxprenolol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00441	0.0356	CcSEcCtD
Oxprenolol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00426	0.0344	CcSEcCtD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00426	0.00859	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00417	0.0084	CbGpPWpGaD
Oxprenolol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00416	0.0335	CcSEcCtD
Oxprenolol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00413	0.0333	CcSEcCtD
Oxprenolol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00401	0.0324	CcSEcCtD
Oxprenolol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00393	0.0317	CcSEcCtD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00365	0.00736	CbGpPWpGaD
Oxprenolol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00361	0.0291	CcSEcCtD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00357	0.0072	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00342	0.00689	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00342	0.00689	CbGpPWpGaD
Oxprenolol—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00336	0.0271	CcSEcCtD
Oxprenolol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00327	0.0264	CcSEcCtD
Oxprenolol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00323	0.026	CcSEcCtD
Oxprenolol—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00322	0.00649	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00318	0.00641	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00318	0.00641	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00315	0.00634	CbGpPWpGaD
Oxprenolol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00312	0.0252	CcSEcCtD
Oxprenolol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00302	0.0243	CcSEcCtD
Oxprenolol—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.00292	0.00589	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.00286	0.00576	CbGpPWpGaD
Oxprenolol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00286	0.023	CcSEcCtD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00283	0.00571	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00283	0.00571	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00278	0.0056	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00272	0.00548	CbGpPWpGaD
Oxprenolol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00271	0.0219	CcSEcCtD
Oxprenolol—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.00254	0.00513	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.00249	0.00501	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00226	0.00457	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00217	0.00438	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00213	0.00429	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.00203	0.00409	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.00199	0.004	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.00197	0.00398	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GRHPR—nephrolithiasis	0.00196	0.00396	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.00193	0.00389	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AGXT—nephrolithiasis	0.00175	0.00353	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	0.00173	0.00348	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.00169	0.0034	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00157	0.00317	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00154	0.0031	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APRT—nephrolithiasis	0.00149	0.003	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	0.00149	0.003	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	0.00144	0.0029	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00143	0.00288	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.00141	0.00283	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.0014	0.00281	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	0.0013	0.00263	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.00128	0.00257	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	0.00117	0.00235	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00117	0.00235	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00114	0.0023	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.00114	0.0023	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AQP1—nephrolithiasis	0.00106	0.00214	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.00101	0.00204	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CHRM3—nephrolithiasis	0.000959	0.00193	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000901	0.00182	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	0.000843	0.0017	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.000824	0.00166	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTH—nephrolithiasis	0.000771	0.00155	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000766	0.00154	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000766	0.00154	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.000754	0.00152	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000546	0.0011	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000494	0.000995	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	0.000387	0.00078	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	0.000378	0.000763	CbGpPWpGaD
